Edition:
United States

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

81.23USD
24 Mar 2017
Change (% chg)

$0.13 (+0.16%)
Prev Close
$81.10
Open
$81.10
Day's High
$81.57
Day's Low
$80.84
Volume
420,986
Avg. Vol
687,193
52-wk High
$87.85
52-wk Low
$62.80

Latest Key Developments (Source: Significant Developments)

Cardinal Health files for potential mixed shelf, size undisclosed - SEC filing
Tuesday, 7 Feb 2017 05:20pm EST 

Cardinal Health Inc :Files for potential mixed shelf, size undisclosed - SEC filing.  Full Article

Cardinal Health reports Q2 EPS $1.02
Tuesday, 7 Feb 2017 07:00am EST 

Cardinal Health Inc - : Second-quarter revenue for pharmaceutical segment increased 5 percent to $29.7 billion . Having completed more than half its fiscal year, company is adjusting its fiscal year 2017 guidance range for non-gaap diluted EPS . Cardinal Health reports second-quarter results for fiscal year 2017 . Q2 revenue $33.1 billion versus I/B/E/S view $33.55 billion . Sees fy 2017 non-gaap earnings per share $5.35 to $5.50 from continuing operations . Q2 gaap earnings per share $1.02 . Q2 earnings per share view $1.23 -- Thomson Reuters I/B/E/S . Pricing in generic pharmaceutical market was a significant headwind for pharmaceutical segment profit and enterprise operating earnings .Q2 non-gaap diluted EPS attributable to Cardinal Health Inc $1.34.  Full Article

Cardinal Health reaches settlement with West Virginia
Monday, 9 Jan 2017 02:09pm EST 

Cardinal Health Inc : Cardinal health reaches settlement with West Virginia . Cardinal health has agreed to pay $20 million to state of West Virginia to resolve issues . West Virginia has released company from any further actions .settlement resolving lawsuit filed in 2012 regarding co's distribution of controlled substances in west virginia between 2007-2012.  Full Article

Cardinal Health Inc says announces civil settlement with DOJ
Friday, 23 Dec 2016 11:15am EST 

Cardinal Health Inc - : Cardinal Health Inc says announces civil settlement with DOJ . Cardinal Health -Reached nationwide settlement with federal government, resolving outstanding civil penalty portion of co's 2012 administrative settlement with U.S. DEA . Cardinal Health Inc - Under settlement, cardinal health has agreed to pay $44 million to Department of Justice (DOJ) to resolve matter .Cardinal Health Inc says DOJ, amongst others, agreed to take no further administrative or civil action on these and related matters.  Full Article

Cardinal Health sees FY 2017 non-gaap EPS $5.40 to $5.60 from cont ops
Monday, 31 Oct 2016 07:00am EDT 

Cardinal Health Inc : Fy2017 earnings per share view $5.59, revenue view $130.84 billion -- Thomson Reuters I/B/E/S . Cardinal health reports first-quarter results for fiscal year 2017 . Q1 revenue $32 billion versus i/b/e/s view $31.04 billion . Sees fy 2017 non-gaap earnings per share $5.40 to $5.60 from continuing operations . Q1 gaap earnings per share $0.96 .Q1 earnings per share view $1.21 -- Thomson Reuters I/B/E/S.  Full Article

Navidea enters into letter of intent with cardinal health for sale of Lymphoseek in North America
Tuesday, 6 Sep 2016 06:59am EDT 

Navidea Biopharmaceuticals Inc: Navidea Biopharmaceuticals enters into letter of intent with cardinal health for the sale of Lymphoseek® in North America . Total consideration to Navidea would be capped at $310 million. . Navidea retains rights to non-competitive diagnostic indications and all therapeutic applications .Navidea would receive $80 million at closing, with future consideration tied to annual sales of Lymphoseek, certain milestones.  Full Article

Medical Developments International signs respiratory deal with Cardinal Health Inc
Tuesday, 9 Aug 2016 12:43am EDT 

Medical Developments International Ltd : MVP signs respiratory deal in the United States . Agreed a distribution deal with Cardinal Health Inc for distribution of "space chamber" anti-static respiratory devices in the US .  Full Article

Cardinal Health Q4 non-gaap earnings per share $1.14
Tuesday, 2 Aug 2016 07:00am EDT 

Cardinal Health Inc : Cardinal Health reports Q4 and fiscal 2016 results, provides fiscal 2017 outlook . Q4 non-gaap earnings per share $1.14 . Sees FY 2017 non-GAAP earnings per share $5.48 to $5.73 from continuing operations . Q4 GAAP earnings per share $1.02 from continuing operations . Q4 revenue $31.4 billion . Q4 earnings per share view $1.13, revenue view $31.19 billion -- Thomson Reuters I/B/E/S . Fy2017 earnings per share view $5.70 -- Thomson Reuters I/B/E/S .Expects a year-over-year decline in its non-gaap earnings per share for Q1 2017 in high-single- to low-double-digit-percent range.  Full Article

Cardinal Health enters into amended and restated 5-yr credit agreement
Tuesday, 21 Jun 2016 10:53am EDT 

Cardinal Health Inc : On June 16, 2016, co entered into an amended and restated five-year credit agreement - SEC Filing . Amended and restated credit agreement extends term of revolving credit facility to June 16, 2021 - SEC Filing . Says effective on June 30, 2016, will reduce its committed receivables sales facility program from $950 million to $700 million . Amended and restated credit agreement increases revolving credit available to company to $1.75 billion Source - http://1.usa.gov/28MtX3s Further company coverage: [CAH.N] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Cardinal Health to prepare NETSPOT doses for Advanced Accelerator Applications
Thursday, 9 Jun 2016 07:51am EDT 

:Advanced Accelerator Applications S.A. says selected Cardinal Health to supply Gallium 68 dotatate doses to u.s. Hospitals and imaging centers.  Full Article

More From Around the Web

BRIEF-Cardinal Health reports 5.8 pct passive stake in Navidea Biopharma

* Cardinal Health, Inc reports 5.8 percent passive stake in navidea biopharmaceuticals inc as of March 3, 2017 - sec filing Source text for Eikon: Further company coverage: